Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$2.71
-7.02%
Mkt Cap $414.35M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (20 analysts)
$5.00
Range $4.00 – $6.00
Implied Upside
+84.5%
Consensus $5.00 vs current $2.71
NASDAQ·Healthcare·Biotechnology
$2.71
-7.02%
Mkt Cap $414.35M
Buy
1
Hold
0
Sell
0
Price Target (20 analysts)
$5.00
Range $4.00 – $6.00
+84.5%
Consensus $5.00 vs current $2.71